Cargando…
FRI526 Geographic Trends In Thyroid Hormone Prescribing In The US: 2010 - 2020
Disclosure: M.D. Ettleson: None. N. Laiteerapong: None. W. Wan: None. A.C. Bianco: Consulting Fee; Self; Abbvie, Acella, Synthonics, Thyron, Madrigal. Introduction: Levothyroxine (LT4) is the first line treatment of hypothyroidism. However, some clinical guidelines suggest a trial of adding triiodot...
Autores principales: | Ettleson, Matthew D, Laiteerapong, Neda, Wan, Wen, Bianco, Antonio C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553534/ http://dx.doi.org/10.1210/jendso/bvad114.1871 |
Ejemplares similares
-
RF23 | PSAT240 Suboptimal Thyroid Hormone Replacement is Associated with Worse Hospital Outcomes
por: Bianco, Antonio C, et al.
Publicado: (2022) -
FRI528 Trends And Components Of Thyroid Status Evaluation In Commercially Insured Adults In The US, 2006-2020
por: Morris, Earl J, et al.
Publicado: (2023) -
FRI479 Resistance To Thyroid Hormone Due To Thyroid Hormone Receptor Alpha (THRA) Gene Mutation
por: Omar Abdelkarim, Jumana, et al.
Publicado: (2023) -
FRI496 A Rare Case Of Thyroid Hormone Resistance Beta
por: Kaur Rai, Harpreet, et al.
Publicado: (2023) -
FRI488 The Effect Of Thyroid Stimulating Hormone On Brown Adipose Tissue In Humans
por: Salej, Laura, et al.
Publicado: (2023)